HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PYPL
PayPal Holdings, Inc.
PYPL's fundamentals are mixed, but it looks cheap: trading at 11x earnings, less than half its usual 26x. Analysts expect earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PYPL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
PYPL's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PYPL.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PYPL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $58.30 | — |
| Current | 11x | $58.30 | — |
| Cheap | 15x | $76.16 | +31% |
| Fair | 26x | $136 | +133% |
| Expensive | 67x | $351 | +503% |
Historical ranges are pointers, not guarantees.
PYPL's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.9x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PYPL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect PYPL's earnings to grow and its profitability to improve, with its revenue holding steady.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PYPL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.87 | +12% |
| Q3 2026 | $5.24 | +5.4% |
| Q2 2026 | $5.29 | +14% |
| Q1 2026 | $5.33 | +20% |
| Q4 2025 | $5.41 | +36% |
| Q3 2025 | $4.97 | +19% |
| Q2 2025 | $4.66 | +13% |
| Q1 2025 | $4.45 | +12% |
| Q4 2024 | $3.99 | +3.9% |
PYPL has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PYPL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
PYPL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6B | +2% |
| Q2 2026 | $8.7B | +4.8% |
| Q1 2026 | $8.4B | +7.2% |
| Q4 2025 | $8.7B | +3.7% |
| Q3 2025 | $8.4B | +7.3% |
| Q2 2025 | $8.3B | +5.1% |
| Q1 2025 | $7.8B | +1.2% |
| Q4 2024 | $8.4B | +4.2% |
PYPL's revenue has grown year over year every quarter since late 2020: $8.6B last quarter, up 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -1.7 points |
| Q1 2026 | 18% | -1.8 points |
| Q4 2025 | 17% | +0.2 points |
| Q3 2025 | 18% | +0.3 points |
| Q2 2025 | 18% | +1.3 points |
| Q1 2025 | 20% | +4.5 points |
| Q4 2024 | 17% | -4.3 points |
PYPL has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over PYPL on cash flow, with more consistent year-over-year improvement.
PYPL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -17% |
| Q2 2026 | $1.8B | +157% |
| Q1 2026 | $903M | -6.3% |
| Q4 2025 | $2.2B | 0% |
| Q3 2025 | $1.7B | +19% |
| Q2 2025 | $692M | -49% |
| Q1 2025 | $964M | -45% |
| Q4 2024 | $2.2B | -11% |
PYPL's free cash flow was $6.3B over the past year, up 13% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PYPL.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has 234M diluted shares, down 6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PYPL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.7% | -24M shares |
| 1 year | -11% | -102M shares |
| 3 years | -22% | -240M shares |
| 5 years | -28% | -329M shares |
| Available history | -28% | -329M shares |
PYPL has the edge over HIMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5B |
| Q2 2026 | $1.6B |
| Q1 2026 | $1.5B |
| Q4 2025 | $1.5B |
| Q3 2025 | $1.5B |
| Q2 2025 | $1.6B |
| Q1 2025 | $1.5B |
| Q4 2024 | $1.3B |
PYPL spent $6.1B buying back its own shares over the past year, up 4% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PYPL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.5x | Very low |
PYPL's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like PYPL.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PYPL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.2 | Neutral |
| Stochastic | 61.9 | Neutral |
PYPL's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PYPL PE vs Financial Services Sector
| Metric | PYPL | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 10 | 63 | 53 pts below |
PYPL is trading at 11x earnings, a 15% discount to the Financial Services sector's median of 13x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PYPL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.5 | 3.3% above |
| 20 week MA | $55.5 | 5% above |
| 50 week MA | $51.5 | 13% above |
| 100 week MA | $61.6 | 5.4% below |
| 200 week MA | $64.5 | 9.6% below |
PYPL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
PYPL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $109.4 | $238.6 | +118% |
| 2021 | $238.6 | $192.0 | -20% |
| 2022 | $192.0 | $69.0 | -64% |
| 2023 | $69.0 | $61.4 | -11% |
| 2024 | $61.4 | $86.9 | +41% |
| 2025 | $86.9 | $60.0 | -31% |
| 2026 YTD | $60.0 | $58.3 | -2.8% |
PYPL has the edge over HIMS on returns for 2026, with the stronger performance.